Survey optimistic on med ed funding

Share this article:
Funding for medical education next year will likely increase or remain stable, according to a Cutting Edge Information survey.

For 2007, 41% of surveyed drug firms predicted a spending hike, 29% forecast a decrease and 29% expected no change. Those promising to spend more said they intend to add events.

“Very few companies are looking to decrease funding or the number of events,” said Elio Evangelista, senior research analyst, Cutting Edge. Why the grantor optimism? “Everybody understands…the rules and the lay of the land and what the repercussions would be [for] not following along with industry practices.”

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?